The Latest in Lung Cancer Treatment and Research

0
Geoffrey Oxnard, MD, and Cloud Paweletz, PhD

Geoffrey Oxnard, MD, and Cloud Paweletz, PhD

Over the last decade, treatment options for lung cancer patients have evolved drastically. Even in just the last few months, promising research has led to new, approved therapies, and researchers anticipate more advances are on the way.

“Drugs are emerging at a rapid pace now,” says Geoffrey Oxnard, MD, of Dana-Farber’s Lowe Center for Thoracic Oncology. “There is a lot of optimism in lung cancer, a lot of options for patients and excitement about new things that are coming.”

Oxnard recently discussed some of these emerging therapies during a live video webchat on the latest lung cancer treatment and research, including new developments in immunotherapy and targeted therapy.

Learn more about these new treatments by watching a recording of the webchat below:

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Latest Tweets

Dana-Farber @danafarber
As recently as up to 10 years ago, #ovariancancer patients had fewer options for treatment. Targeted therapies have… https://t.co/tPLFcyIwpN
Dana-Farber @danafarber
When bone marrow can no longer keep up with the body's needs for new blood cells, it can lead to serious consequenc… https://t.co/gMhLId8U0y
Dana-Farber @danafarber
Itchy skin has many causes, including dryness & allergies, but only rarely does it signal that a person has cancer:… https://t.co/jZfr7PbBfq

Patient and Family Blogs

Patients and families of patients at Dana-Farber often chronicle their own experiences with cancer.

Here are some blogs that you can follow.